1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470 "Cancer")
Fax: (212) 888-0000
1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
Original Article
You have full text access to this OnlineOpen article
Cognitive effects of hormone therapy in men with prostate cancer
A Review
Article first published online: 29 JUL 2008
DOI: 10.1002/cncr.23658
Copyright © 2008 American Cancer Society
Additional Information
How to Cite
Nelson, C. J., Lee, J. S., Gamboa, M. C. and Roth, A. J. (2008), Cognitive effects of hormone therapy in men with prostate cancer. Cancer, 113: 1097–1106. doi: 10.1002/cncr.23658
Publication History
- Issue published online: 20 AUG 2008
- Article first published online: 29 JUL 2008
- Manuscript Accepted: 13 MAR 2008
- Manuscript Revised: 25 FEB 2008
- Manuscript Received: 11 DEC 2007
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , , , , , , Androgen deprivation and thromboembolic events in men with prostate cancer, Cancer, 2012, 118, 11Direct Link:
- 2, , , Cognitive changes associated with ADT: a review of the literature, Asian Journal of Andrology, 2012, 14, 2, 232
- 3, , , , , , Development of psychophysiological motoric reactivity is influenced by peripubertal pharmacological inhibition of gonadotropin releasing hormone action – Results of an ovine model, Psychoneuroendocrinology, 2012,
- 4, , , , , Does pharmacological castration as adjuvant therapy for prostate cancer after radiotherapy affect anxiety and depression levels, cognitive functions and quality of life?, Psycho-Oncology, 2012, 21,Direct Link:
- 5, , , , Hormone therapy for prostate cancer and the risk of stroke: a 5-year follow-up study, BJU International, 2012, 109, 7Direct Link:
- 6, , , Impact of androgen deprivation therapy on depressive symptoms in men with nonmetastatic prostate cancer, Cancer, 2012, 118, 7Direct Link:
- 7, , , , , , Lamin A/C protein is overexpressed in tissue-invading prostate cancer and promotes prostate cancer cell growth, migration and invasion through the PI3K/AKT/PTEN pathway, Carcinogenesis, 2012, 33, 4, 751
- 8, , , , , , , , , Preoperative characteristics of high-Gleason disease predictive of favourable pathological and clinical outcomes at radical prostatectomy, BJU International, 2012, 109, 12Direct Link:
- 9, , , Quality of life issues in men undergoing androgen deprivation therapy: a review, Asian Journal of Andrology, 2012, 14, 2, 226
- 10, , , Review of recent studies on interventions for cognitive deficits in patients with cancer, Expert Review of Anticancer Therapy, 2012, 12, 2, 255
- 11, , , , Spatial anxiety relates to spatial abilities as a function of working memory in children, The Quarterly Journal of Experimental Psychology, 2012, 65, 3, 474
- 12, , Testosterone impairs the acquisition of an operant delayed alternation task in male rats, Hormones and Behavior, 2012, 61, 1, 57
- 13, , , , , , , , , , , The hormonal pathway to cognitive impairment in older men, The journal of nutrition, health & aging, 2012, 16, 1, 40
- 14
- 15, , , , , , An Update on Cancer- and Chemotherapy-Related Cognitive Dysfunction: Current Status, Seminars in Oncology, 2011, 38, 3, 431
- 16, , An Update on the Changing Indications for Androgen Deprivation Therapy for Prostate Cancer, Prostate Cancer, 2011, 2011, 1
- 17, , Androgen deprivation therapy for prostate cancer: not so simple, Asian Journal of Andrology, 2011, 13, 2, 187
- 18, , , , Cognitive dysfunction and cancer: which consequences in terms of disease management?, Psycho-Oncology, 2011, 20, 12Direct Link:
- 19, , , , , Individualized Decision-Making for Older Men With Prostate Cancer: Balancing Cancer Control With Treatment Consequences Across the Clinical Spectrum, Seminars in Oncology, 2011, 38, 2, 309
- 20, , , , Long-term Cognitive Impairment in Older Adult Twins Discordant for Gynecologic Cancer Treatment, The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 2011, 66A, 12, 1343
- 21, , Management of Side Effects of Androgen Deprivation Therapy, Endocrinology & Metabolism Clinics of North America, 2011, 40, 3, 655
- 22, , , Oxidative stress and androgen receptor signaling in the development and progression of castration-resistant prostate cancer, Free Radical Biology and Medicine, 2011, 51, 7, 1320
- 23, , , Pharmacotherapeutic Management of Locally Advanced Prostate Cancer, Drugs, 2011, 71, 8, 1019
- 24, , , , , , , , , , , Prepubertal gonadotropin-releasing hormone analog leads to exaggerated behavioral and emotional sex differences in sheep, Hormones and Behavior, 2011, 59, 1, 22
- 25, , , , The Role of Testosterone in Sexuality and Paraphilia—A Neurobiological Approach. Part II: Testosterone and Paraphilia, The Journal of Sexual Medicine, 2011, 8, 11Direct Link:
- 26, , , , , , , , , , , Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer, British Journal of Cancer, 2011, 106, 2, 405
- You have free access to this content27, , Androgen deprivation therapy for prostate cancer and its complications, Trends in Urology, Gynaecology & Sexual Health, 2010, 15, 3Direct Link:
- 28, , , , , Androgen Deprivation Therapy for Prostate Cancer: Recommendations to Improve Patient and Partner Quality of Life, The Journal of Sexual Medicine, 2010, 7, 9Direct Link:
- 29, , , , , , , Androgen-Deprivation Therapy in Prostate Cancer: A European Expert Panel Review, European Urology Supplements, 2010, 9, 7, 675
- 30, , , , , , , Cognitive effects of androgen deprivation therapy in an older cohort of men with prostate cancer, Journal of Geriatric Oncology, 2010, 1, 1, 13
- 31, , , , , , , Cognitive effects of androgen deprivation therapy in an older cohort of men with prostate cancer, Critical Reviews in Oncology/Hematology, 2010, 75, 2, 152
- 32, , , , , , , , , , , , , Levels of sex hormones have limited effect on cognition in older men with or without prostate cancer, Critical Reviews in Oncology/Hematology, 2010, 73, 2, 167
- 33, , , , Luteinizing-hormone Releasing Hormone Therapy and the Risk of Death From Alzheimer Disease, Alzheimer Disease & Associated Disorders, 2010, 24, 1, 85
- 34, , Management of prostate cancer recurrence after definitive radiation therapy, Cancer Treatment Reviews, 2010, 36, 2, 91
- 35, , , , , Prostate Specific Antigen at the Initial Diagnosis of Metastasis to Bone in Patients After Radical Prostatectomy, The Journal of Urology, 2010, 184, 1, 157
- 36, , , , , Cognitive impairment in men treated with luteinizing hormone–releasing hormone agonists for prostate cancer: a controlled comparison, Supportive Care in Cancer, 2009, 18, 1, 21
- 37, , , , , , Effet de la suppression androgénique par agonistes de la LH-RH sur les fonctions cognitives de patients atteints de cancer de prostate, Progrès en Urologie, 2009, 19, 1, 47
- 38, Improving Flexibility and Quality of Life for Your Patients: A Must?, European Urology Supplements, 2009, 8, 12, 857
- 39, , , , , , , , , , , , Le traitement hormonal du cancer de la prostate chez le patient âgé, Progrès en Urologie, 2009, 19, S151
- 40, , Management of localized prostate cancer in men over 65 years, Current Opinion in Urology, 2009, 19, 3, 309
- 41, , Prostate cancer: Issues in psychosomatic medicine, Current Psychiatry Reports, 2009, 11, 3, 205
- 42
- 43, Hospital Pharmacy Pulse - Recent Publications on Medications and Pharmacy, Hospital Pharmacy, 2008, 43, 11, 937